| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |